ArticleInternational journal of general medicine2024

Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations.

Xiang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.